Hexarelin-induced growth hormone, cortisol, and prolactin release: A dose-response study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4338-4341

  Massoud, Ahmed F ^a   Hindmarsh, Peter C ^a   Brook, Charles G D ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HEXARELIN; HYDROCORTISONE; PROLACTIN;

ADULT; ARTICLE; BODY GROWTH; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG POTENCY; ENZYME ACTIVITY; GROWTH HORMONE RELEASE; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; HYPERPROLACTINEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE;

ADULT; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; GROWTH SUBSTANCES; HUMANS; HYDROCORTISONE; INSULIN; MALE; OLIGOPEPTIDES; PROLACTIN; THYROTROPIN;

EID: 0029845438     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.12.4338     Document Type: Article

References (28)

1. Deghenghi R, Cananzi MM, Torsello A, Battisti C, Muller EE. 1994 GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci. 54:1321-1328.
2. Ghigo E, Arvat E, Gianotti L, et al. 1994 Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. J Clin Endocrinol Metab. 78:693-698.
3. Bowers CY. 1993 GH releasing peptides-structure and kinetics. J Pediatr Endocrinol. 6:21-31.
4. Laron Z, Bowers CY, Hirsch D, et al. 1993 Growth hormone releasing activity of growth hormone-releasing peptide-1 (a synthetic hexapeptide) in children and adolescents. Acta Endocrinol (Copenh). 129:424-426.
5. Tiulpakov AN, Brook CGD, Pringle PJ, Peterkova VA, Volevodz NN, Bowers CY. 1995 GH responses to intravenous bolus of GH releasing hormone and GH releasing peptide-2 separately and in combination in adult volunteers. Clin Endocrinol (Oxf). 43:347-350.
6. Cordido F, Penalva A, Dieguez C, Casanueva FF. 1993 Massive growth hormone discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab. 76:819-822.
7. 2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. J Clin Endocrinol Metab. 77:842-845.
8. Giustina A, Bussi AR, Deghenghi R, et al. 1995 Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess. J Endocrinol. 146:227-232.
9. Robinson BM, Friberg RD, Bowers CY, Barkan AL. 1992 Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone. J Clin Endocrinol Metab. 75:1121-1124.
10. Jaffe CA, Ho PJ, Demott-Friberg R, Bowers CY, Barkan AL. 1993 Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab. 77:1641-1647.
11. Huhn WC, Hartman ML, Pezzoli SS, Thorner MO. 1993 Twenty-four-hour growth hormone (GH)-releasing peptide (GHRH) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus. J Clin Endocrinol Metab. 76:1202-1208.
12. Massoud AF, Hindmarsh PC, Brook CGD. 1995 Hexarelin induced growth hormone (GH) release is influenced by exogenous growth hormone. Clin Endocrinol (Oxf). 43:617-621.
13. Sartorio A, Conti A, Ferrero S, Spada A, Faglia G. 1995 GH responsiveness to repeated GHRH or hexarelin administration in normal adults. J Endocrinol Invest. 18:718-722.
14. Miller JD, Tannenbaum GS, Colle E, Guyda HJ. 1982 Daytime pulsatile growth hormone secretion during childhood and adolescence. J Clin Endocrinol Metab. 55:989-994.
15. Hindmarsh PC, Smith PJ, Brook CGD, Matthews DR. 1987 The relationship between height velocity and GH secretion in short prepubertal children. Clin Endocrinol (Oxf). 27:581-591.
16. Hindmarsh PC, Matthews DR, Brook CGD. 1988 Growth hormone secretion in children determined by time series analysis. Clin Endocrinol (Oxf). 29:35-44.
17. Ilson BE, Jorkasky DK, Curnow RT, Stote RM. 1989 Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab. 69:212-214.
18. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 70:975-982.
19. Imbimbo BP, Mant T, Edwards M, et al. 1994 Growth hormone-releasing activity of hexarelin in humans: a dose-response study. Eur J Clin Pharmacol. 46:421-425.
20. Massoud AF, Hindmarsh PC, Pringle PJ, Brook CGD. 1995 Are the actions of the growth hormone-releasing peptides really specific [Abstract]? J Endocrinol. 144:P54.
21. Brain C, Hindmarsh PC, Brook CGD, Matthews DR. 1988 Continuous subcutaneous growth hormone releasing factor analogue augments growth hormone secretion in normal male subjects with no desensitization of the somatotroph. Clin Endocrinol (Oxf). 28:543-549.
22. Saini S, Hindmarsh PC, Matthews DR, et al. 1991 Reproducibility of 24-hour serum growth hormone profile in man. Clin Endocrinol (Oxf). 34:455-562.
23. Laron Z, Frenkel J, Gil-Ad I, et al. 1994 Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin). Clin Endocrinol (Oxf). 41:539-541.
24. Spoudeas HA, Winrow AP, Hindmarsh PC, Brook CGD. 1994 Low-dose growth hormone-releasing tests: a dose-response study. Eur J Endocrinol. 131:238-245.
25. Bowers CY, Momany FA, Reynolds GA, Hong A. 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 114:1537-1545.
26. Korbonits M, Trainer PJ, Besser GM. 1995 The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin Endocrinol (Oxf). 43:365-371.
27. Bowers CY, Alster DK, Frentz JM. 1992 The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab. 74:292-298.
28. Bowers CY. 1994 Editorial: on a peptidomimetic growth hormone-releasing peptide. J Clin Endocrinol Metab. 79:940-942.